Camarillo-based Interlink Electronics reports increased revenues
Camarillo-based Interlink Electronics, a tech company that focuses on manufacturing sensors that are used in portable electronic devices, saw revenues increase by 6 percent from $2.7 million during the second quarter last year to $2.8 million this year. Interlink posted earnings of 8 cents per share, an improvement of 1 cent from the same quarter Read More →
Thousand Oaks’ Ceres sees stock price spike after patent approved
Ceres, a Thousand Oaks based agriculture-biotechnology company, saw shares spike 373 percent Wednesday after the company received a patent for its iCODE multi-gene trait development system. Ceres shares started the day at just 95 cents per share, and soared all the way to $4.80 when the markets opened at 6:30 a.m. PST. Ceres closed the Read More →
Revenues down but Thousand Oaks-based Teledyne beats estimates
Thousand Oaks-based Teledyne Technologies beat analyst estimates when it reported second-quarter earnings on July 30 but the company still saw a sharp decline in net income. Teledyne posted earnings of $1.34 per share, barely beating analyst estimates of $1.33 per share. Second-quarter revenues were down by 3.2 percent from the second-quarter of 2014, from $597.1 Read More →
Camarillo-based Salem Media Group beats expectations
Camarillo-based Salem Media Group beat analyst expectations when it reported second-quarter earnings of 14 cents per share on Aug. 5. Analysts predicted Salem Media Group would earn just 4 cents per share. Salem’s revenues declined by 2 percent from $68.6 million during the second quarter of last year to $67.3 million. This still beat analyst Read More →
Westlake Village-based Kythera Biopharmaceuticals reports second quarter loss
Westlake Village-based Kythera Biopharmaceuticals missed analyst estimates when it released second quarter earnings on Aug. 6. Kythera lost $1.44 per share, missing analyst estimates of a loss of $1.10 per share. For the quarter, Kythera lost $37.2 million, compared to $19.5 million during the second quarter of 2014. On June 17, Allergan announced that it Read More →